ETA-DOC-0004·Compound index·Rev 1·Methodology v0.1Provisional — reviewer not yet appointed
compound index · I, page 3 of 3 · methodology v0.1 · reviewer not yet appointed
Compound index · I ETA-DOC-0004

Compound index — I

490 substances begin with I. 4 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 90 of them, Iris Missouriensis Whole – izenivetmab.

US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Iris Missouriensis Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Antimalarial [EPC]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007986
Iris tectorum CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007987
Iris Tenax CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Market presence1 US product listings · 4 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007988
Iris Tenax Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007989
Iris versicolor CA-NHP Not yet graded
CA licensed ingredient
Market presence68 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007990
Iris Versicolor Root US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]
Market presence131 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007991
Iris Versicolor Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007992
Iris X Germanica Nothovar. Florentina Root US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007993
Iris X Germanica Root US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007994
Iron CA-NHPETALYNEU-CLAIMUS-DRUG C/contestedband 4
EU claims 8 authorised / 3 refusedCA licensed ingredientUS: drug for further processing
also: Iron Powder
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Acidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]
Market presence199 US product listings · 5,033 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Iron contributes to normal cognitive development of children”AuthorisedArt.14(1)(b)EFSA opinion
“Iron contributes to normal cognitive function”AuthorisedArt.13(1)EFSA opinion
“Iron contributes to normal energy-yielding metabolism”AuthorisedArt.13(1)EFSA opinion
“Iron contributes to normal formation of red blood cells and haemoglobin”AuthorisedArt.13(1)EFSA opinion
“Iron contributes to normal oxygen transport in the body”AuthorisedArt.13(1)EFSA opinion
“Excessive hair loss in non-menopausal women”Non-authorisedArt.13(5)EFSA opinion
“Iron has a role in the process of cell division”AuthorisedArt.13(1)EFSA opinion
“Iron contributes to the normal function of the immune system”AuthorisedArt.13(1)EFSA opinion
“Iron contributes to the reduction of tiredness and fatigue”AuthorisedArt.13(1)EFSA opinion
“Iron affects activity of heart, liver and muscles.”Non-authorisedArt.13(1)EFSA opinion
“Iron is needed to allow the body metabolise drugs and other substances. Iron contributes to the body's ability to metabolise drugs and other substances. Iron is needed for the metabolism of drugs.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM, US-DRUG — 3 of 7 registers
Etalyn identifierETA-C-007995
Iron Dextran US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAnalogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Earliest US approval1957
Market presence7 US product listings · 4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007996
iron oxide EU-MED Not yet graded
EU medicine: Application withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007998
Iron oxide (Fe2O3), mixture with zinc oxide CA-NHP Not yet graded
CA licensed ingredient
Market presence29 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007999
Iron Pentacarbonyl US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAnalogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Calculi Dissolution Agent [EPC]; Folate Analog [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008000
Iron Peptonate CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008001
Iron Sucrose US-DRUG Not yet graded
US: anda
Class as recordedIron [CS]; Parenteral Iron Replacement [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]
Earliest US approval2000
Market presence36 US product listings · 4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008002
Iron(iii) ion EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007997
Irvingia gabonensis CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
Market presence443 Canadian licensed products
Parts in scopeSeeds
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-008003
Irvingia gabonensis seed extract CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008004
IS-741 Sodium Monohydrate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008005
Isatis indigotica CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008006
Isatis root CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008007
Isatis tinctoria CA-NHP Not yet graded
CA licensed ingredient
Market presence323 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008008
Isatis Tinctoria Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008009
Isatis Tinctoria Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008010
Isatuximab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedAntibodies; CD38-directed Antibody Interactions [MoA]; CD38-directed Cytolytic Antibody [EPC]; L01XC38
Market presence5 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008011
Isatuximab-Irfc US-DRUG Not yet graded
Earliest US approval2020
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008012
isavuconazole EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ02AC05
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008013
Isavuconazonium Sulfate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAzole Antifungal [EPC]; Azoles [CS]; Cytochrome P450 3A4 Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]
Earliest US approval2015
Market presence14 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008014
Iscotrizinol US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008015
Islatravir US-DRUG Not yet graded
US: bulk ingredient
Class as recordedHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
Earliest US approval2026
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008016
islelizumab-jsgr US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008017
Isobutyryl fentanyl US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesN-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-008018
Isocarboxazid US-DRUG Not yet graded
US: bulk ingredient
Class as recordedMonoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]
Earliest US approval1959
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008019
Isoconazole Nitrate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008020
Isodon amethystoides CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008021
Isodon lophanthoides CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008022
Isodon rubescens CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008023
Isoetharine Mesylate US-DRUG Not yet graded
Earliest US approval1978
Market presence36 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008024
Isoflavones CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 2 refusedCA licensed ingredient
Market presence2 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“helps to reduce untoward effects of climacterium e.g. hot flush, exudation, strong heartbeat”Non-authorisedArt.13(1)EFSA opinion
“helps to maintain mobility of joint during and after climacterium”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM — 2 of 7 registers
Etalyn identifierETA-C-008025
Isoflupredone Acetate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008026
Isoflurane US-DRUG Not yet graded
US: anda
Class as recordedGeneral Anesthesia [PE]; General Anesthetic [EPC]
Earliest US approval1979
Market presence13 US product listings · 7 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008027
Isoflurophate US-DRUG Not yet graded
Earliest US approval1957
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008028
Isolated soy protein EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Protein-rich soybean component has been shown to lower/reduce blood cholesterol; blood cholesterol lowering may reduce the risk of (coronary) heart disease.”Non-authorisedArt.14(1)(a)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008029
Isoleucine CA-NHPETALYNUS-DRUG D/not supportedband 5
CA licensed ingredientUS: anda
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Amino Acid [EPC]; Amino Acids [CS]
Market presence74 US product listings · 1,440 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008030
Isoleucyl-prolyl-proline CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008031
Isoleucyl-prolyl-proline (IPP) and valyl-prolyl-proline (VPP) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Peptides IPP and VPP help to maintain normal blood pressure”Non-authorisedArt.13(5)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008032
Isomalto-oligosaccharides EU-CLAIM Not yet graded
EU claims 0 authorised / 5 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Can help friendly bacteria grow in the colon and digestive system as part of a healthy lifestyle”Non-authorisedArt.13(1)EFSA opinion
“Can help friendly bacteria grow in the colon and digestive system as part of a healthy lifestyle”Non-authorisedArt.13(1)EFSA opinion
“Can help to keep your cholesterols levels healthy as part of a healthy lifestyle”Non-authorisedArt.13(1)EFSA opinion
“Can help to maintain a normal bowel function as part of a healthy lifestyle”Non-authorisedArt.13(1)EFSA opinion
“Helps to keep blood sugar levels low after each meal as part of a healthy lifestyle.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008033
Isomaltooligosaccharides CA-NHP Not yet graded
CA licensed ingredient
Market presence43 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008034
Isomaltulose EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Isomaltulose contributes to normal energy- yielding metabolism”Non-authorisedArt.13(5)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008035
Isomethadone US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesIsoamidone
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-008036
Isomethyl-.alpha.-Ionone US-DRUG Not yet graded
US: otc monograph final
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008037
Isoniazid US-DRUG Not yet graded
US: anda
Class as recordedAntimycobacterial [EPC]
Earliest US approval1952
Market presence35 US product listings · 48 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008038
Isopropamide Iodide US-DRUG Not yet graded
Earliest US approval1957
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008039
Isopropanol CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008040
Isopropyl Alcohol CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: bulk ingredient
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Cell-mediated Immunity [PE]; Decreased Cell Wall Integrity [PE]
Earliest US approval2000
Market presence686 US product listings · 6 FDA applications · 18 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008042
Isopropyl Myristate US-DRUG Not yet graded
US: bulk ingredient for human prescription compounding
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008043
Isopropyl Palmitate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008041
Isoproterenol Sulfate US-DRUG Not yet graded
US: anda
Class as recordedAdrenergic beta-Agonists [MoA]; beta-Adrenergic Agonist [EPC]
Earliest US approval1948
Market presence35 US product listings · 40 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008044
Isosorbide US-DRUG Not yet graded
Earliest US approval1974
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008045
Isosorbide Dinitrate US-DRUG Not yet graded
US: anda
Class as recordedArteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]; Nitrate Vasodilator [EPC]; Nitrates [CS]
Earliest US approval1959
Market presence64 US product listings · 44 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008046
Isosorbide Mononitrate US-DRUG Not yet graded
US: anda
Class as recordedNitrate Vasodilator [EPC]; Nitrates [CS]; Vasodilation [PE]
Earliest US approval1991
Market presence67 US product listings · 23 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008047
Isosulfan Blue US-DRUG Not yet graded
US: anda
Earliest US approval1981
Market presence15 US product listings · 9 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008048
Isotonic Sodium Chloride Solution US-DRUG Not yet graded
US: drug for further processing
Class as recordedIncreased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008049
Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) nitro-1H-benzimidazole-1-ethanamine US-CSA Not yet graded
CSA Schedule Inarcotic
also: Isotonitazene -5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) nitro-1H-benzimidazole-1-ethanamine
Class as recordedDEA: narcotic / opioid
DEA other namesN,N-Diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-008050
Isotretinoin US-DRUG Not yet graded
US: anda
Class as recordedRetinoid [EPC]; Retinoids [CS]
Earliest US approval1982
Market presence109 US product listings · 18 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008051
Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) US-CSA Not yet graded
CSA Schedule Inarcotic
also: Isovaleryl fentanyl -N-phenylbutanamide)
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-008052
Isoxsuprine Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008053
Isradipine US-DRUG Not yet graded
US: anda
Class as recordedCalcium Channel Antagonists [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]
Earliest US approval1990
Market presence9 US product listings · 5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008054
Issatchenkia Orientalis Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fungal Proteins [CS]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008055
Istisociclib US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008056
Istradefylline EU-MEDUS-DRUG Not yet graded
EU medicine: RefusedUS: bulk ingredient
Class as recordedN04
Earliest US approval2019
Market presence9 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008057
IT-139 US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008058
Itraconazole EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAzole Antifungal [EPC]; Azoles [CS]; Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]
Earliest US approval1992
Market presence36 US product listings · 20 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008059
IVA Angustifolia Pollen US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008060
IVA Angustifolia Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Allergens [Chemical/Ingredient]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008061
IVA Annua Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Animal Fur [CS]; Antigens; Cell-mediated Immunity [PE]
Market presence30 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008062
IVA Axillaris Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008063
Ivabradine EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedC01EB17; Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]; Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]
Earliest US approval2015
Market presence33 US product listings · 8 FDA applications · 5 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008064
Ivacaftor EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedChloride Channel Activation Potentiators [MoA]; Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]
Earliest US approval2012
Market presence33 US product listings · 9 FDA applications · 4 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008065
Ivacaftor, Tezacaftor US-DRUG Not yet graded
Earliest US approval2018
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008066
Ivermectin US-DRUG Not yet graded
US: anda
Class as recordedAntiparasitic [EPC]; Pediculicide [EPC]
Earliest US approval1996
Market presence69 US product listings · 15 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008067
Ivermectin B1A US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008068
Ivosidenib EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: bulk ingredient
Class as recordedCytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Isocitrate Dehydrogenase 1 Inhibitor [EPC]; Isocitrate Dehydrogenase 1 Inhibitors [MoA]
Earliest US approval2018
Market presence4 US product listings · 1 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008069
Ivosidenib Isonicotinamide US-DRUG Not yet graded
US: drug for further processing
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008070
Ixabepilone US-DRUG Not yet graded
Earliest US approval2007
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008071
Ixazomib Citrate EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedL01XG03; Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]
Earliest US approval2015
Market presence7 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008072
Ixekizumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedInterleukin-17A Antagonist [EPC]; Interleukin-17A Antagonists [MoA]; L04AC13
Earliest US approval2016
Market presence6 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-008073
Ixora coccinea CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008074
izenivetmab EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008075